Sobell Department of Motor Neuroscience, UCL Institute of Neurology, University College London, 33 Queen Square, London WC1N 3BG, UK.
The National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 3BG, UK.
Nat Rev Neurol. 2017 Apr;13(4):244-255. doi: 10.1038/nrneurol.2017.34. Epub 2017 Mar 17.
Stroke is the leading cause of complex adult disability in the world. Recovery from stroke is often incomplete, which leaves many people dependent on others for their care. The improvement of long-term outcomes should, therefore, be a clinical and research priority. As a result of advances in our understanding of the biological mechanisms involved in recovery and repair after stroke, therapeutic opportunities to promote recovery through manipulation of poststroke plasticity have never been greater. This work has almost exclusively been carried out in preclinical animal models of stroke with little translation into human studies. The challenge ahead is to develop a mechanistic understanding of recovery from stroke in humans. Advances in neuroimaging techniques now enable us to reconcile behavioural accounts of recovery with molecular and cellular changes. Consequently, clinical trials can be designed in a stratified manner that takes into account when an intervention should be delivered and who is most likely to benefit. This approach is expected to lead to a substantial change in how restorative therapeutic strategies are delivered in patients after stroke.
中风是全球导致成年人残疾的主要原因。中风后的恢复往往不完整,这使得许多人需要依赖他人照顾。因此,改善长期预后应该是临床和研究的重点。由于我们对中风后恢复和修复涉及的生物学机制的理解有所提高,通过操纵中风后的可塑性来促进恢复的治疗机会从未如此之大。这项工作几乎完全是在中风的临床前动物模型中进行的,很少有转化为人类研究。未来的挑战是在人类中风康复中建立一种机制性的理解。神经影像学技术的进步现在使我们能够将恢复的行为描述与分子和细胞变化联系起来。因此,可以设计分层临床试验,考虑干预措施应该何时进行以及谁最有可能受益。这种方法有望导致中风后患者的恢复性治疗策略的提供方式发生重大变化。